Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lymphoma
Interventions: DRUG: Atorvastatin|DRUG: Placebo
Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI)